Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

Jonathan D.C. Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, Zainab Abdali, Trish M. Hepburn*, Frances Griffiths, Alan Montgomery, Jane Daniels, Alice Manley, Gillian Dean, Lindsay K. Armstrong-Buisseret

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    3 Citations (SciVal)
    Original languageEnglish
    Article number241
    JournalBMC Women's Health
    Volume23
    Issue number1
    DOIs
    Publication statusPublished (VoR) - Dec 2023

    Keywords

    • Bacterial vaginosis
    • Lactic acid
    • Metronidazole
    • Recurrence
    • Sexual health
    • Side effects

    Fingerprint

    Dive into the research topics of 'Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial'. Together they form a unique fingerprint.

    Cite this